JP Morgan Chase’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $85K | Buy |
53,156
+2,000
| +4% | +$3.55K | ﹤0.01% | 5918 |
|
|
2025
Q4 | $72.6K | Sell |
51,156
-56,445
| -52% | -$82.3K | ﹤0.01% | 6067 |
|
|
2025
Q3 | $176K | Buy |
107,601
+5,821
| +6% | +$6.47K | ﹤0.01% | 5582 |
|
|
2025
Q2 | $74.4K | Sell |
101,780
-121,345
| -54% | -$105K | ﹤0.01% | 5740 |
|
|
2025
Q1 | $180K | Buy |
223,125
+173,384
| +349% | +$200K | ﹤0.01% | 5283 |
|
|
2024
Q4 | $68.6K | Sell |
49,741
-11,642
| -19% | -$13.1K | ﹤0.01% | 5894 |
|
|
2024
Q3 | $63.8K | Buy |
61,383
+1,073
| +2% | +$1.47K | ﹤0.01% | 5899 |
|
|
2024
Q2 | $104K | Sell |
60,310
-166,769
| -73% | -$336K | ﹤0.01% | 5497 |
|
|
2024
Q1 | $543K | Sell |
227,079
-208,587
| -48% | -$513K | ﹤0.01% | 4739 |
|
|
2023
Q4 | $1.45M | Sell |
435,666
-4,944,542
| -92% | -$13.2M | ﹤0.01% | 4079 |
|
|
2023
Q3 | $20.1M | Sell |
5,380,208
-348,710
| -6% | -$1.61M | ﹤0.01% | 1675 |
|
|
2023
Q2 | $24.5M | Sell |
5,728,918
-253,617
| -4% | -$1.5M | ﹤0.01% | 1550 |
|
|
2023
Q1 | $40.9M | Sell |
5,982,535
-522,328
| -8% | -$4.05M | 0.01% | 1197 |
|
|
2022
Q4 | $51.5M | Buy |
6,504,863
+379,618
| +6% | +$2.92M | 0.01% | 1099 |
|
|
2022
Q3 | $58.9M | Sell |
6,125,245
-360,986
| -6% | -$3.65M | 0.01% | 973 |
|
|
2022
Q2 | $47M | Sell |
6,486,231
-89,312
| -1% | -$777K | 0.01% | 1074 |
|
|
2022
Q1 | $84.9M | Sell |
6,575,543
-114,205
| -2% | -$1.45M | 0.01% | 915 |
|
|
2021
Q4 | $107M | Sell |
6,689,748
-481,119
| -7% | -$8.41M | 0.01% | 851 |
|
|
2021
Q3 | $115M | Buy |
7,170,867
+1,076,809
| +18% | +$15.8M | 0.01% | 797 |
|
|
2021
Q2 | $84.3M | Buy |
6,094,058
+897,952
| +17% | +$12.7M | 0.01% | 972 |
|
|
2021
Q1 | $75.9M | Buy |
5,196,106
+242,524
| +5% | +$4.12M | 0.01% | 975 |
|
|
2020
Q4 | $86.1M | Buy |
4,953,582
+223,225
| +5% | +$3.97M | 0.01% | 834 |
|
|
2020
Q3 | $89M | Buy |
4,730,357
+192,453
| +4% | +$3.58M | 0.02% | 736 |
|
|
2020
Q2 | $81M | Buy |
4,537,904
+413,659
| +10% | +$7M | 0.02% | 721 |
|
|
2020
Q1 | $66.9M | Buy |
4,124,245
+666,775
| +19% | +$12.3M | 0.02% | 706 |
|
|
2019
Q4 | $62.3M | Sell |
3,457,470
-215,176
| -6% | -$3.97M | 0.01% | 853 |
|
|
2019
Q3 | $74.4M | Sell |
3,672,646
-591,159
| -14% | -$11.8M | 0.01% | 776 |
|
|
2019
Q2 | $91.6M | Sell |
4,263,805
-478,784
| -10% | -$8.32M | 0.02% | 704 |
|
|
2019
Q1 | $64.7M | Buy |
4,742,589
+1,010,708
| +27% | +$13.5M | 0.01% | 838 |
|
|
2018
Q4 | $33.8M | Buy |
3,731,881
+1,543,553
| +71% | +$17.9M | 0.01% | 1112 |
|
|
2018
Q3 | $36.1M | Sell |
2,188,328
-44,570
| -2% | -$790K | 0.01% | 1224 |
|
|
2018
Q2 | $31.3M | Buy |
2,232,898
+187,830
| +9% | +$2.69M | 0.01% | 1266 |
|
|
2018
Q1 | $22.6M | Buy |
2,045,068
+120,574
| +6% | +$1.32M | ﹤0.01% | 1429 |
|
|
2017
Q4 | $16.9M | Buy |
1,924,494
+173,292
| +10% | +$1.86M | ﹤0.01% | 1701 |
|
|
2017
Q3 | $23.6M | Buy |
1,751,202
+359,491
| +26% | +$4.76M | 0.01% | 1393 |
|
|
2017
Q2 | $20M | Sell |
1,391,711
-238,776
| -15% | -$4.59M | ﹤0.01% | 1452 |
|
|
2017
Q1 | $34.5M | Buy |
1,630,487
+65,619
| +4% | +$1.61M | 0.01% | 1133 |
|
|
2016
Q4 | $44.1M | Sell |
1,564,868
-366,111
| -19% | -$10.2M | 0.01% | 962 |
|
|
2016
Q3 | $51.7M | Buy |
1,930,979
+54,042
| +3% | +$1.47M | 0.01% | 813 |
|
|
2016
Q2 | $31.7M | Sell |
1,876,937
-245,614
| -12% | -$4.61M | 0.01% | 1076 |
|
|
2016
Q1 | $45.1M | Buy |
2,122,551
+466,388
| +28% | +$7.64M | 0.01% | 865 |
|
|
2015
Q4 | $38M | Buy |
1,656,163
+281,193
| +20% | +$7.24M | 0.01% | 944 |
|
|
2015
Q3 | $27.6M | Sell |
1,374,970
-149,941
| -10% | -$4.56M | 0.01% | 1067 |
|
|
2015
Q2 | $44.1M | Buy |
1,524,911
+240,208
| +19% | +$6.07M | 0.01% | 946 |
|
|
2015
Q1 | $39.3M | Buy |
1,284,703
+549,384
| +75% | +$14.2M | 0.01% | 1003 |
|
|
2014
Q4 | $12M | Buy |
+735,319
| New | +$10.4M | ﹤0.01% | 1818 |
|
Other funds holding CHRS
VCM
SB
KKRC
CM
CWG